ONS Journal Activity 2017: PD-1 Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events

ONS Journal Activity 2017: PD-1 Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events

Contact hours
0.50
Next start date
None Available

PLEASE NOTE: You DO NOT have to sign up for this educational activity. Instead, click the article link below to begin. 

This educational activity is based upon a peer-reviewed article published in the August 2017 Clinical Journal of Oncology Nursing Supplement. To receive CNE credit for this activity you must

  • Read the entire article START HERE
  • Submit an evaluation through the link listed in the article.

As an exclusive benefit to ONS members, this is a free CNE activity. For nonmembers, please note that article access includes a fee.

 

ILNA Breakdown

OCN®

0.5 ILNA points may be applied toward:

  • 0.5 points: Symptom Management 

AOCNP® and AOCNS®

0.5 ILNA points may be applied toward:

  • 0.5 points: Side Effect and Symptom Management

The Oncology Nursing Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

How to Sign Up
1 Log In
2 No sessions available

Menu